Logo

American Heart Association

  59
  0


Final ID: TAC105

High Salt Intake Enhances the REVERSIR-Induced Recovery of Blood Pressure after Angiotensinogen siRNA Treatment

Abstract Body: Introduction: One subcutaneous injection of angiotensinogen-targeting small-interfering RNA (AGT siRNA) is able to suppress hepatic AGT synthesis for >6 months, thus inducing prolonged blood pressure-lowering effects.
Hypothesis: Both the reverse siRNA silencing technology (REVERSIR, RVR) and a high salt diet (HSD) can reverse the blood pressure drop in AGT siRNA-treated spontaneously hypertensive rats within several days. To also evaluate such reversal in hypotensive conditions, we treated salt-depleted, normotensive Wistar Kyoto (WKY) rats with AGT siRNA, and then exposed them to RVR, HSD or RVR + HSD.
Methods: Ten-week old WKY rats were placed on a low salt diet and treated with 10 mg/kg AGT siRNA. Three weeks later they were given RVR (0.1, 1, or 10 mg/kg), HSD or HSD + RVR 10 mg/kg. Mean arterial pressure (MAP) was monitored by radiotelemetry, and circulating AGT and renin were measured by enzyme-kinetic assay.
Results: Baseline MAP was 105±3 mm Hg. AGT siRNA lowered MAP by »12 mm Hg and suppressed AGT by >95%, while renin rose 5-fold. RVR 0.1 mg/kg was without effect. RVR 1 mg/kg restored AGT by 50% and partially normalized renin, allowing MAP to return to baseline. RVR 10 mg/kg fully normalized AGT and renin, and induced the same MAP return as RVR 1 mg/kg. HSD did not affect AGT, and partially normalized renin and MAP. RVR 10 mg/kg + HSD fully normalized AGT and renin, and this combination was accompanied by the largest MAP rise, allowing MAP to rise above baseline. The MAP rise after RVR + HSD equaled the sum of the separate effects of these treatments. All MAP rises were maximal within 2-3 days.
Conclusions: AGT siRNA (10 mg/kg) lowers MAP in WKY rats under low salt diet conditions. RVR at a dose of 1 mg/kg fully restored MAP, and this effect was not different at higher RVR doses. HSD partially restored MAP, and enhanced the RVR-induced recovery of blood pressure after AGT siRNA treatment under hypotensive conditions.
  • Cruz-lopez, Edwyn  ( Erasmus MC , Rotterdam , Netherlands )
  • Van Veghel, Richard  ( Erasmusmc , Rotterdam , Netherlands )
  • Garrelds, Ingrid  ( Erasmusmc , Rotterdam , Netherlands )
  • Kasper, Anne  ( Alnylam Pharmaceuticals , Roslindale , Massachusetts , United States )
  • Wassarman, Kelly  ( Alnylam Pharmaceuticals , Roslindale , Massachusetts , United States )
  • Tu, Ho-chou  ( Alnylam Pharmaceuticals , Roslindale , Massachusetts , United States )
  • Zlatev, Ivan  ( Alnylam Pharmaceuticals , Roslindale , Massachusetts , United States )
  • Danser, Jan  ( ERASMUS MC , Rotterdam , Netherlands )
  • Author Disclosures:
    Edwyn Cruz-Lopez: DO NOT have relevant financial relationships | Richard Van veghel: DO NOT have relevant financial relationships | Ingrid Garrelds: DO NOT have relevant financial relationships | Anne Kasper: No Answer | Kelly Wassarman: No Answer | Ho-Chou Tu: No Answer | Ivan Zlatev: No Answer | Jan Danser: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alnylam Pharmaceuticals:Active (exists now)
Meeting Info:
Session Info:

Poster Session 1 and Reception (includes TAC Poster Competition)

Thursday, 09/04/2025 , 05:30PM - 07:00PM

Poster Session

More abstracts on this topic:
A Study Using Team Based Hypertension Care Focused on Black Patients to Inform a Future Randomized Trial

Manandhar Srista, Taylor Yhenneko, Bosworth Hayden, Pokharel Yashashwi, Chhetri Sunit, Sutton Danielle, Saha Animita, Kaur Suneet, Brown Josh, Moore Justin, Callahan Kate, Williamson Jeff

Antihypertensive Efficacy of Angiotensin Receptor Blockers with and without Inverse Agonism: A Systematic Review and Network Meta-analysis

Liu Jing, Geng Jialu, Liu Jiakun, Hu Lei, Du Huimin, Hung Ivan Tjong A, Fang Jia

More abstracts from these authors:
Kidney arteriolar responses to liver-targeted small interference RNA (siRNA) targeting angiotensinogen in diabetic rats: comparison with other renin-angiotensin system blockers

Cruz-lopez Edwyn, Martini Alexandre, Foster Don, Zlatev Ivan, Kasper Anne, Sequeira Maria Luisa, Gomez Ariel, Danser Jan

Persistent beneficial effects of angiotensinogen small interfering RNA (siRNA) and valsartan in spontaneously hypertensive rats after drug removal

Cruz-lopez Edwyn, Ye Dien, Van Veghel Richard, Garrelds Ingrid, Kasper Anne, Wassarman Kelly, Tu Ho-chou, Zlatev Ivan, Danser Jan

You have to be authorized to contact abstract author. Please, Login
Not Available